2019 Clinical Trials Epilepsy Presentation 
Cannabis Law Report
JANUARY 13, 2020
12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.
The Joint Blog
JANUARY 31, 2021
The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. Case presentation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
MARCH 7, 2022
Therefore, it makes sense that CBN is most commonly found in aged or improperly stored cannabis, and hardly ever present in fresh flower or low-temp extractions. In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. What can the current clinical trials tell us?
Cannabis Law Report
NOVEMBER 1, 2021
The substance is allowed in Hong Kong as long as other prohibited ingredients derived from cannabis are not present in the products. Since March 2019, Customs and Excise Department officers detected 10 cases in which a total of 194 imported CBD products were found to have traces of THC. The city vows zero tolerance to drugs.
The Joint Blog
JANUARY 23, 2020
. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known.”
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high.
Canna Law Blog
APRIL 17, 2020
Below are five things I learned about Hemp CBD for pet products in preparing for my presentation at CBD Considerations in the Northwest. THC binds to the CB1 receptors, but the way that CBD interacts with ECS is not fully understood in humans or animals, despite the fact that Epidiolex has been approved as a drug for treating epilepsy.
Expert insights. Personalized for you.
66 
Let's personalize your content